DB
NAUT icon

Dmitry Balyasny’s Nautilus Biotechnolgy NAUT Stock Holding History

Dmitry Balyasny’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
+13,184
New +$34.8K ﹤0.01% 2925
2022
Q2 		– Sell
-29,212
Closed -$127K – 3028
2022
Q1 		$127K Buy
+29,212
New +$120K ﹤0.01% 2106

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Dmitry Balyasny's NAUT Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 13,184 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #2925 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in NAUT as recently as Q1 2022.

Dmitry Balyasny first reported a position in NAUT in Q1 2022 and has held it in 2 quarters since. The position peaked at $127K in Q1 2022. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Dmitry Balyasny held 13,184 shares of Nautilus Biotechnolgy worth $24.7K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Dmitry Balyasny position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2925 holding.
  • Dmitry Balyasny first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 2 quarters since.
  • Dmitry Balyasny's Nautilus Biotechnolgy position peaked at $127K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.